Akron’s Recombinant Human Basic Fibroblast Growth Factor-155 (rHu bFGF-155) product is manufactured following all relevant cGMP guidelines for ancillary materials.Product Features:Manufacturing•Expressed in E. coli•Animal-derived component free•Tag-free pharmaceutical biosimilar processing•In-house sterile filtration with aseptic filling and lyophilization•All raw materials are compliant, controlled, and traceable under Akron’s Quality Management System (QMS)Stability•Currently on a long-term stability program•Store at 2-8 °C•Transport on cold packsFor Use StatementFor research use or further manufacturing use in ex vivo cell therapy applications. This product is not intended for direct in vivo use or for direct clinical use as a drug, therapeutic, biologic, or medical device.